Deborah A. Scollard
-
- Radiopharmaceutical Chemistry and Applications 25
- Monoclonal and Polyclonal Antibodies Research 15
- Medical Imaging Techniques and Applications 3
- Oncology top 5%
- HER2/EGFR in Cancer Research 17
- Drug Transport and Resistance Mechanisms 3
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
- Structural Biology top 10%
-
- Lung Cancer Treatments and Mutations 4
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Raymond M. ReillyJudy WangKatherine A. VallisSusan J. DoneKristin McLartyZhongli CaiBart CornelissenClaire Holloway
- Journals
- Journal of Controlled Release (1 paper)International Journal of Cancer (1 paper)Pharmaceutical Research (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Deborah A. Scollard
35 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 76
- Radiology, Nuclear Medicine and Imaging 788
- Oncology 590
- Biomaterials 160
- Structural Biology 15
- Cancer Research 85
Countries citing papers authored by Deborah A. Scollard
This map shows the geographic impact of Deborah A. Scollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Scollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Scollard more than expected).
Fields of papers citing papers by Deborah A. Scollard
This network shows the impact of papers produced by Deborah A. Scollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Scollard. The network helps show where Deborah A. Scollard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Deborah A. Scollard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Necrosis-Avid Small Molecule HQ4-DTPA as a Multimodal Imaging Agent for Monitoring Radiation Therapy-Induced Tumor Cell Death | 2016 | 1 |
| 2 | 2016 | 12 | |
| 3 | 2013 | 19 | |
| 4 | 2013 | 22 | |
| 5 | 2012 | 82 | |
| 6 | 2012 | 14 | |
| 7 | 2011 | 32 | |
| 8 | 2009 | 58 | |
| 9 | 2009 | 33 | |
| 10 | 2008 | 50 | |
| 11 | 2008 | 103 | |
| 12 | 2007 | 31 | |
| 13 | 2007 | 10 | |
| 14 | 2006 | 56 | |
| 15 | 2006 | 7 | |
| 16 | 2006 | 42 | |
| 17 | 2005 | 52 | |
| 18 | 2005 | 116 | |
| 19 | 2005 | 34 | |
| 20 | 2004 | 58 |
About Deborah A. Scollard
Deborah A. Scollard is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Biomaterials, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (25 papers), HER2/EGFR in Cancer Research (17 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Lung Cancer Treatments and Mutations (4 papers), Medical Imaging Techniques and Applications (3 papers), Drug Transport and Resistance Mechanisms (3 papers), RNA Interference and Gene Delivery (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (788 citations), Oncology (590 citations) and Biomaterials (160 citations). Deborah A. Scollard has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Raymond M. Reilly, Judy Wang, Katherine A. Vallis, Susan J. Done, Kristin McLarty, Zhongli Cai, Bart Cornelissen, Claire Holloway, Conrad Chan and Paul Chen. Their work appears in journals such as Journal of Controlled Release, International Journal of Cancer and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.